Treatment for hypertension in Middle East, North Africa, Afghanistan & Pakistan
Middle East, North Africa, Afghanistan & Pakistan: Treatment for hypertension was 40.2% in 2019. ▲ Rising
Treatment for hypertension in Middle East, North Africa, Afghanistan & Pakistan, 1990–2019
Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of adults ages 30-79 with hypertension.
Analysis
Middle East, North Africa, Afghanistan & Pakistan recorded 40.2% for treatment for hypertension in 2019. That is the highest value across all 30 years on record.
The figure is up 0.2% on the previous year and up 9.3% over ten years.
Over the whole period, treatment for hypertension in Middle East, North Africa, Afghanistan & Pakistan peaked at 40.2% in 2019 and was at its lowest, 21.3%, in 1990.
Middle East, North Africa, Afghanistan & Pakistan ranks 20th of 43 groups on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 30 years of available data.
Treatment for hypertension in Middle East, North Africa, Afghanistan & Pakistan, year by year
| Year | % of adults ages 30-79 with hypertension | Change |
|---|---|---|
| 1990 | 21.3% | — |
| 1991 | 21.8% | +2.2% |
| 1992 | 22.3% | +2.3% |
| 1993 | 22.9% | +2.5% |
| 1994 | 23.4% | +2.4% |
| 1995 | 24.1% | +2.8% |
| 1996 | 24.7% | +2.6% |
| 1997 | 25.4% | +2.9% |
| 1998 | 26.2% | +3.0% |
| 1999 | 27.0% | +3.1% |
| 2000 | 27.8% | +3.2% |
| 2001 | 28.8% | +3.3% |
| 2002 | 29.8% | +3.4% |
| 2003 | 30.8% | +3.6% |
| 2004 | 32.0% | +3.6% |
| 2005 | 33.0% | +3.4% |
| 2006 | 34.1% | +3.3% |
| 2007 | 35.1% | +2.8% |
| 2008 | 36.0% | +2.6% |
| 2009 | 36.8% | +2.1% |
| 2010 | 37.5% | +2.0% |
| 2011 | 38.1% | +1.6% |
| 2012 | 38.6% | +1.3% |
| 2013 | 39.0% | +1.1% |
| 2014 | 39.4% | +0.9% |
| 2015 | 39.7% | +0.7% |
| 2016 | 39.9% | +0.7% |
| 2017 | 40.0% | +0.2% |
| 2018 | 40.1% | +0.3% |
| 2019 | 40.2% | +0.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 23.9% | 21.3% | 27.0% | 10 |
| 2000s | 32.4% | 27.8% | 36.8% | 10 |
| 2010s | 39.3% | 37.5% | 40.2% | 10 |
Countries ranked near Middle East, North Africa, Afghanistan & Pakistan
More health data for Middle East, North Africa, Afghanistan & Pakistan
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 1.93 % change on previous year (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, per capita 0.0387 units per person (2025)
- Population ages 40-44, female, annual growth rate 3.33 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate 3.14 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0337 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, per capita 0.0344 units per person (2025)
- Population ages 40-44, female, per capita 0.0305 units per person (2025)
All data for Middle East, North Africa, Afghanistan & Pakistan →
Frequently asked questions
- What is treatment for hypertension in Middle East, North Africa, Afghanistan & Pakistan?
- Treatment for hypertension in Middle East, North Africa, Afghanistan & Pakistan was 40.2% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
- What is the highest treatment for hypertension recorded in Middle East, North Africa, Afghanistan & Pakistan?
- The highest recorded value was 40.2% in 2019.
- What is the lowest treatment for hypertension recorded in Middle East, North Africa, Afghanistan & Pakistan?
- The lowest recorded value was 21.3% in 1990.
- How does Middle East, North Africa, Afghanistan & Pakistan rank for treatment for hypertension?
- Middle East, North Africa, Afghanistan & Pakistan ranks 20th out of 43 groups with data for 2019.
- Is treatment for hypertension rising or falling in Middle East, North Africa, Afghanistan & Pakistan?
- Over the last ten years it is up 9.3%. The long-run trend across the full record is rising.
- Where does this Middle East, North Africa, Afghanistan & Pakistan data come from?
- The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Treatment for hypertension (% of adults ages 30-79 with hypertension). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.